Ho thibela lefu la tsoekere la mofuta oa 1, lisele tsa manyeme tse ikarabellang bakeng sa ho hlahisa insulin ho batho ba kotsing e kholo ea lefu lena li lokela ho thibeloa hore li senyehe. Ho latela Mokhatlo oa Canadian Diabetes Association, ha ho na ha ho mokhoa o sebetsang le o bolokehileng hajoale ho thibela lefu lena, esita le haeba re ka buisana le ngoana e sa le monyenyane haholo bophelong ba ngoana eo ho nkoang hore o kotsing. Ka hona, mehato leha e le efe ea ho thibela lefu la tsoekere la mofuta oa 1 e lokela ho etsoa ka tšebelisano e haufi le ngaka 'me maemong a mang, e le karolo ea thuto ea liteko.⁴.

Lipatlisiso tse tsoelang pele

• Vitamin D. Liphuputso tse 'maloa tsa tlhokomeliso li bontšitse hore tlatsetso ea vithamine D ea bana ba banyenyane e theotse haholo kotsi ea ho ba le lefu la tsoekere la mofuta oa 1 (litekanyetso tsa letsatsi le letsatsi li ne li tloha ho 400 IU ho isa ho 2 IU).¹³. Leha ho le joalo, ha ho na teko ea bongaka e seng e fihlile ho netefatsa sena.¹¹. Ka lebaka la ho ba sieo ha likotsi tse amanang le ho noa vithamine D le melemo ea eona e mengata ea bophelo bo botle, lingaka tse ling li e khothalletsa e le mokhoa oa ho thibela;
• immunotherapy. Ena ke tsela e tšepisang ka ho fetisisa, 'me ke eona eo bo-rasaense ba tsetelang haholo ho eona. Immunotherapy e ikemiselitse ho lumella sesole sa 'mele ho "mamella" lisele tsa manyeme tse ikarabellang bakeng sa ho hlahisa insulin. Ho ntse ho lekoa mefuta e mengata ea immunotherapy, mohlala⁵ : ente e entsoeng ka li-antigen tse tsoang manyemeng a motho ea lokelang ho phekoloa; transplant autologous ea lisele tsa 'mele oa ho itšireletsa mafung ho tlosa lisele tse senyang le ho lumella nts'etsopele ea lisele tse ncha tse mamellang; le tšelo ea mali a nkiloeng mothapong oa mokhubu nakong ea tsoalo (ho bana ba banyenyane);
• Vithamine B3. Matsatsi a vitro le liteko tsa liphoofolo li tšehetse khopolo-taba ea hore niacinamide (vithamine B3) e ka ba le phello e sireletsang liseleng tsa beta tsa pancreatic. Liteko tse seng kae tsa pele tsa kliniki le tsona li hōlisitse tšepo ena⁶. Leha ho le joalo, liphuputso tse khōloanyane ha lia hlahisa liphello tse kholisang. Mohlala, joalo ka karolo ea European Nicotinamide Diabetes Intervention Trial (ENDIT)⁷, litekanyetso tse phahameng tsa niacinamide kapa placebo li fuoe batho ba 552 ba kotsing ea ho tšoaroa ke lefu la tsoekere la mofuta oa 1 (ba amanang haufi-ufi ba amehileng, boteng ba li-autoantibodies khahlanong le manyeme le tlhahlobo e tloaelehileng ea ho mamella tsoekere). Niacinamide ha ea ka ea fokotsa kotsi ea ho ba le lefu la tsoekere.
• Ho kenya litekanyetso tse tlase tsa insulin. E 'ngoe ea mekhoa ea thibelo e lekiloeng ke ho fana ka litekanyetso tse nyane tsa insulin ho batho ba kotsing. Mokhoa ona o 'nile oa hlahlojoa e le karolo ea Teko ea Thibelo ea Lefu la Lefu la tsoekere - Mofuta oa 1^8,9. Phekolo ea insulin e ne e se na phello ea thibelo ntle le sehlotšoana se kotsing e kholo, moo ho qala ha lefu la tsoekere ho ileng ha lieha hanyane.

E 'ngoe ea liqholotso liphuputsong ke ho shebana le batho ba kotsing ea ho tšoaroa ke lefu lena. Ponahalo maling ea li-antibodies khahlano le lisele tsa beta tsa manyeme (autoantibodies) ke e 'ngoe ea matšoao a ithutoang. Li-antibodies tsena li ka ba teng lilemo pele lefu le qala. Kaha ho na le mefuta e 'maloa ea li-antibodies tsena, ke potso ea ho fumana hore na ke life tse tsejoang esale pele ka lefu lena, le hore na ke bokae.¹⁰.

Sheba leqephe la rona la Mathata a Lefu la Lefu la tsoekere.